Lakatos Lehel-Barna, Bolognese Manuel, Oesterreich Mareike, Müller Martin, Karwacki Grzegorz Marek
Department of Neurology and Neurorehabilitation, Lucerne, Switzerland.
Department of Radiology and Nuclear Medicine, Section Diagnostic and Invasive Neuroradiology, Lucerne Cantonal Hospital, Lucerne, Switzerland.
Front Physiol. 2024 Dec 19;15:1423195. doi: 10.3389/fphys.2024.1423195. eCollection 2024.
Ischemic stroke in patients with a systemic tumor disease or cancer not in remission (active tumors) is less well understood. Some aspects of such paraneoplastic strokes remind on a generalized cerebrovascular disorder. We hypothesized that cerebrovascular regulation in active tumor patients with a stroke is different from other patients with stroke who have no active tumor disease.
Within the first 72 h after the acute ischemic stroke, cerebral blood flow regulation was analyzed by means of transfer function analysis between middle cerebral artery blood flow velocity and blood pressure with estimation of coherence, gain and phase in the very low (0.02-0.07 Hz), low (0.07-0.20 Hz) and high frequencies (0.20-0.5 Hz) in four stroke groups: active tumors, inactive tumors (untreated and in remission), hypertensive lacunar stroke (LS), and non-hypertensive embolic stroke (NHES).
The 4 groups did not differ regarding age, sex distribution, and brain infarct size on magnet resonance imaging Between the four stroke groups, phase was not different in any frequency range in both hemispheres. Gain was highest (either significant or by trend) in the active tumor group in the HF range in comparison to all other stroke subgroups, it was also higher in the LF range in the stroke affected hemisphere when compared to the LS group. The HF gain findings were independent of end-tidal CO2 levels but exhibited some dependency of coherence.
The high gain can be interpreted as a generalized high vascular resistance. The cerebrovascular regulation in active tumor patients seems to exhibit some analogy to hypertensive patients with lacunar stroke.
clinicaltrials.gov, identifier NCT04611672.
对于患有全身性肿瘤疾病或癌症且未缓解(活动性肿瘤)的患者发生缺血性卒中的情况,人们了解较少。此类副肿瘤性卒中的某些方面让人联想到全身性脑血管疾病。我们推测,患有活动性肿瘤的卒中患者的脑血管调节与没有活动性肿瘤疾病的其他卒中患者不同。
在急性缺血性卒中后的最初72小时内,通过分析大脑中动脉血流速度与血压之间的传递函数,估计四个卒中组在极低频率(0.02 - 0.07赫兹)、低频率(0.07 - 0.20赫兹)和高频(0.20 - 0.5赫兹)下的相干性、增益和相位,来分析脑血流调节情况。这四个卒中组分别为:活动性肿瘤组、非活动性肿瘤组(未治疗和已缓解)、高血压性腔隙性卒中(LS)组和非高血压性栓塞性卒中(NHES)组。
四组在年龄、性别分布以及磁共振成像显示的脑梗死大小方面没有差异。在四个卒中组之间,两个半球在任何频率范围内的相位均无差异。与所有其他卒中亚组相比,活动性肿瘤组在高频范围内的增益最高(显著或呈趋势),与LS组相比,在卒中受累半球的低频范围内增益也更高。高频增益结果与呼气末二氧化碳水平无关,但表现出一定的相干性依赖性。
高增益可解释为全身性高血管阻力。活动性肿瘤患者的脑血管调节似乎与高血压性腔隙性卒中患者有一些相似之处。
clinicaltrials.gov,标识符NCT04611672。